Recruiting OBSERVATIONAL NCT06368388
Bacteriophage Therapy for Difficult-to-treat Infections: the Implementation of a Multidisciplinary Phage Task Force (PHAGEFORCE)
Sponsor: KU Leuven
Conditions
Chronic Rhinosinusitis (Diagnosis) Hidradenitis Suppurativa Musculoskeletal Infection Pulmonary Infection Sepsis
Interventions
Prospective data collection
Updated 3 times since 2024 Last updated: Apr 10, 2024 Started: Jun 1, 2021 Primary completion: Dec 1, 2024 Completion: Jun 1, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Chronic Rhinosinusitis (Diagnosis) and Hidradenitis Suppurativa and is currently actively recruiting participants. KU Leuven leads this study, which shows 3 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
May 2024 — Jul 2024 [monthly]
Recruiting
First recorded
Jun 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- KU Leuven
- Universitaire Ziekenhuizen KU Leuven
Data source: Universitaire Ziekenhuizen KU Leuven
For direct contact, visit the study record on ClinicalTrials.gov .